Portfolio company
Univ8 Genomics
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company provides next-generation sequencing kits and analysis software to clinical laboratories for the diagnosis and monitoring of cancers including leukaemia and lymphoma.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Predicta Biosciences
This company develops blood-based genomic diagnostic tests for clinicians and pharmaceutical partners to monitor and treat blood cancers.
Arima Genomics
This company develops 3D genomic sequencing kits and clinical diagnostic tests for researchers and pharmaceutical companies to identify cancer-driving genetic alterations.
Cambridge Cancer Genomics
This company develops precision oncology software for clinicians to monitor treatment response and detect cancer relapse using genomic data and blood samples.
Enumera Molecular
The company develops genomic analysis platforms and workflows for clinical laboratories to perform rapid and cost-effective liquid biopsy and diagnostic testing.
Genomill Health
Genomill Health develops targeted sequencing technology for liquid biopsies to assist clinical laboratories and pharmaceutical companies with precision cancer diagnostics.
NGeneBio
This company develops next-generation sequencing based cancer diagnostic panels and clinical analysis software for hospitals, research institutions and pharmaceutical companies.
GenomOncology
This company develops software platforms to analyse and interpret genomic data for molecular pathology labs, clinical oncologists and research institutions.
Spotlight Pathology
This company develops artificial intelligence software for clinicians to analyse digital pathology images for the diagnosis and classification of blood cancers.
